Representative before the EPO

Company dna olswang germany llp
no operation time available
1 office
active in Legal Services

Uli Foerstl has worked on the following 4 EPO patent applications which have been published in the last five years:

EP12004148

Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein

IPC classification:
C12N 15/86
Agent:
Mathias Ricker, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Uli Foerstl, Olswang Germany LLP
Status:
EXAMINATION IN PROGRESS
EP13002972

Semi-live respiratory syncytial virus vaccine

IPC classification:
A61K 39/155, C12N 5/10, C12N 7/00, C12N 15/86
Agent:
Mathias Ricker, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Uli Foerstl, Olswang Germany LLP
Status:
GRANT OF PATENT INTENDED
EP13727047

METHOD FOR EXPRESSION OF HETEROLOGOUS PROTEINS USING A RECOMBINANT NEGATIVE-STRAND RNA VIRUS VECTOR

IPC classification:
C12N 5/071, C12N 15/86
Agent:
Mathias Ricker, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Uli Foerstl, Olswang Germany LLP
Status:
EXAMINATION IN PROGRESS
EP11769781

GENERATION OF VIROSOME PARTICLES

IPC classification:
A61K 39/145, C12N 15/82
Agent:
Mathias Ricker, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Agent:
Uli Foerstl, Olswang Germany LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature